Recall Ledger

Carbamazepine Tablets recall (SUN PHARMACEUTICAL INDUSTRIES INC)

DrugClass IIOngoing

Summary: SUN PHARMACEUTICAL INDUSTRIES INC is recalling Carbamazepine Tablets, USP, 200mg, 1000 count bottles, Rx only, Manufactured by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Distributed by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC 51672-4005-3.. Reason: CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing.

What is being recalled

Carbamazepine Tablets, USP, 200mg, 1000 count bottles, Rx only, Manufactured by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Distributed by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC 51672-4005-3.

Why

CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing

How serious is it

Class II is the middle level: using or being exposed to this product may cause temporary or medically reversible health problems, and the chance of serious harm is remote.

Where it was sold

US Nationwide.

How to tell if yours is affected

Lot # AD94033, Exp Date: 5/31/2028.

What to do

Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.

Recall facts

Recall numberD-0770-2026
CategoryDrug
AgencyU.S. Food and Drug Administration (FDA)
SeverityClass II
StatusOngoing
Recall startedAugust 3, 2026
ReportedAugust 26, 2026
CompanySUN PHARMACEUTICAL INDUSTRIES INC
Company locationPrinceton, NJ, United States
Initiated byVoluntary: Firm initiated
Quantity1968 Bottles (1000Tablets/Bottle)

More recalls from SUN PHARMACEUTICAL INDUSTRIES INC · all drug recalls · recalls from August 2026

Official FDA record